Asian press release distribution

Press Releases for Tuesday, December 2, 2025

Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025 23:01 HKT/SGT

NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI 22:43 HKT/SGT

Fujitsu develops new technology to support human-robot collaboration 22:26 HKT/SGT

AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation 22:18 HKT/SGT

Doubleview Provides Cobalt Resource Summary for the Hat Polymetallic Deposit in Advance of Updated MRE and PEA 21:59 HKT/SGT

Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks 21:55 HKT/SGT

OpenAI以創始成員身份加入全球反詐聯盟，強化全球對抗AI驅動詐騙的應對能力 21:00 HKT/SGT

OpenAI以创始成员身份加入全球反诈骗联盟，强化全球应对人工智能驱动型诈骗的能力 21:00 HKT/SGT

OpenAI Joins the Global Anti-Scam Alliance as Foundation Member to Strengthen Global Response Against AI-Enabled Scams 21:00 HKT/SGT

Digital Realty and BW Digital Partner to Support Expansion of Cross-Border Connectivity Between Singapore and Batam 15:49 HKT/SGT

GEN 宣布針對阿茲海默症及其他神經退化性疾病之試驗藥物 SUL-238 取得全新第一期試驗正面數據 13:00 HKT/SGT

GEN 宣布针对阿尔茨海默病及其他神经退行性疾病的试验性药物 SUL-238 取得新的积极 I 期临床试验数据 13:00 HKT/SGT

GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases 13:00 HKT/SGT

AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation 12:22 HKT/SGT

君聖泰醫藥公佈HTD1801與達格列淨的頭對頭III期臨床研究結果展現控糖優勢及心血管代謝優效獲益 10:59 HKT/SGT

富士通、偽・誤情報や新たなAIリスクに対応する国際コンソーシアム「Frontria」を創立 10:50 HKT/SGT

君圣泰医药公布HTD1801与达格列净的头对头III期临床研究结果展现控糖优势及心血管代谢优效获益 10:16 HKT/SGT

2025年度論壇「香港數字金融中心建設的機遇與挑戰」暨「跨境金融及金融創新服務大獎」颁獎典禮隆重舉行 09:26 HKT/SGT

ACN Search:

Asian Financial Forum kicks off 2026 as region's first major event of 2026


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575